Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Arch Surg. 2011 Jun;146(6):724–732. doi: 10.1001/archsurg.2011.129

Table 3.

Surgical findings

Characteristic Number (%)


Patient numbers
 Total number patients entered 46
 Number undergoing surgery 44 (100%)(a)
 Number tumor resected 42 (91%) (b)
Age surgery (yrs)
 Mean ± SEM 49 ± 2
 [range] [27.5-81)
Duration diagnosis to surgery (yrs)
 Mean ± SEM 5.3 ± 1.1
 [range] [0.1-18.8]
Primary PET location/size (surgery)
 Location
  Pancreas 30 (68%)
  Duodenum 12 (27%)
  Other 5 (11%)(c)
 Largest Primary size (cm)
  Mean ± SEM 5 ± 0.6
  [range] [0.4-15]
Metastases found at surgery
 Lymph node involvement 31 (70%)
 Liver metastases 18 (41%)(d)
Tumor extent at surgery
 Primary only 8 (18%)
 Primary plus lymph node involvement 31 (70%)
 With liver involvement 20 (48%)(d)
Invasion/encasement of major vessel 15 (36%)(e)
(a)

Two patients refused surgery.

(b)

Two patients with gastrinomas had unresectable disease. One with diffuse peritoneal implants/diffuse small liver metastases and the second with complete encasement of the IVC/portal vein with arterial invasion with bleeding. The number of patients undergoing surgery was used as 100% in this table.

(c)

Other refers to 1 patient with a primary gastrinoma in the bile duct (n=1), liver (n=2), heart (n=1) and lymph node (n=1).

(d)

Two patients had primary gastrinoma of the liver.

(e)

One patient had invasion of the heart by a gastrinoma, twelve encasement of the SMV or PV, one SMA and one involvement of the IVC.